Survivor Pool Picks - Week 7

Survivor Pool Picks - Week 7

Up next

2020 Playoffs Week 3

On this week's episode of The Survivor Pool Podcast, we discuss the 2020 playoffs. We look over every game this week and discuss why you should or shouldn't use your bullets on it. Tune in to this episode to learn who you should look out for!See omnystudio.com/listener for privac ...  Show more

2019 Week Eleven!

On this week's episode of The Survivor Pool Podcast, we discuss Week 11 matchups. We looking over every game this week and discuss why you should or shouldn't use your bullets on it. Tune in to this episode to learn who you should look out for in Week 11!SummaryOn this week's epi ...  Show more

Recommended Episodes

Rick Doblin
Flow Sessions with Jason Silva

Rick Doblin is the founder and executive director of the Multi-Disciplinary Association for Psychedelic Studies, MAPS. He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of ...  Show more

PT500 – Shulgin Farm and the Future of Psychedelic Drug Development, with Paul F. Daley, Ph.D.
Psychedelics Today

In this episode, Joe interviews Paul F. Daley, Ph.D., who worked with Sasha Shulgin in his lab for the last seven years of his life, helping him finish (and co-authoring) "The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds." He is now the co-founder, ...  Show more

#1854 - Rick Strassman
The Joe Rogan Experience

Rick Strassman is a Clinical Associate Professor of Psychiatry at the University of New Mexico School of Medicine. He is the author of numerous scientific papers and books, among them "DMT: The Spirit Molecule." His most recent, "The Psychedelic Handbook: A Practical Guide to Psi ...  Show more

#2319 - Rick Doblin
The Joe Rogan Experience

Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated Lykos Therapeutics (formerly MAPS Public Benefit ...  Show more